Figure 2 of
Millar, Mol Vis 2008;
14:10-19.Figure 2 of
Millar, Mol Vis 2008;
14:10-19.
Figure 2. Effects of routes of intraocular injections, titers of viral vector, and use of anti-CD40L antibody on the intensity and duration of GFP expression evaluated by in vivo fluorescence grades
At day 0, Ad5.CMV-GFP, at a titer of 1x107 pfu (A and C) or 1x08 pfu (B and D), was injected intracamerally (A and B) or intravitreally (C and D) with (open symbols) or without (closed symbols) immunomodulation by intraperitoneal treatment of anti-CD40L antibody. In vivo fluorescence in the eyes was evaluated and fluorescence grades assigned at the indicated days by a researcher who was masked of the treatments. The fluorescence grades were further analyzed as the integrated fluorescence (E) by summation of the area under the curve of each animal. All data were presented as mean and SEM.
